why choose us

First received: April 25, 2024

Clinical Trial: A Conversational Agent (Cecebot) to Improve Insomnia in Stage I-III Breast Cancer Survivors

Study Status: COMPLETED

Recruit Status: COMPLETED

Condition: Anatomic Stage I Breast Cancer AJCC v8
Anatomic Stage II Breast Cancer AJCC v8
Anatomic St

Study Type: INTERVENTIONAL


Official Title: A Crossover Randomized Controlled Trial to Investigate the Acceptability and Efficacy of Cecebot, a Conversational Agent for Insomnia After Breast Cancer

Brief Summary: This clinical trial evaluates the effect of conversational agent, Cecebot, on improving insomnia in stage I-III breast cancer survivors. Sleep disturbance ranks among the top concerns reported by breast cancer survivors and is associated with poor quality of life. Many breast cancer survivors also have decreased physical activity, which may also have a negative impact on sleep and quality of life. Cognitive behavioral therapy for insomnia (CBTi) and physical activity interventions have individually been reported…

Read more